Substituted dispensing and generic prescription under adverse impact.

Published: 2006-04-17 06:59:00

Updated: 2006-04-17 06:59:00

The false bio-equivalency test recently detected by the KFDA seems to give a serious adverse impact to the pharmacist group's plans for the substituted dispensing and the prescriptions in generic drug names.

The pharmacist group strongly urged the KFDA to uncover the suspicion over the manipu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK